The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Condition(s):Coronary Artery DiseaseLast Updated:January 30, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Coronary Artery DiseaseLast Updated:January 30, 2019Completed
Condition(s):Heart FailureLast Updated:June 5, 2019Unknown status
Condition(s):TGA – Transposition of Great ArteriesLast Updated:January 31, 2024Recruiting
Condition(s):Spinal Cord InjuriesLast Updated:May 24, 2019Completed
Condition(s):Ventilator Lung; Newborn; Hemodynamic Instability; EchocardiographyLast Updated:November 7, 2023Completed
Condition(s):In-stent Restenosis After Carotid Artery StentingLast Updated:October 16, 2019Completed
Condition(s):COPD; Heart Failure; Parkinson Disease; Arthritis; Old Age; Cachexia; Stroke SequelaeLast Updated:March 28, 2024Recruiting
Condition(s):Diabetes Mellitus, Type 2Last Updated:August 25, 2022Recruiting
Condition(s):Contrast-Induced Acute Kidney InjuryLast Updated:August 7, 2023Recruiting
Condition(s):Atrial FibrillationLast Updated:July 27, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.